Biotech

All Articles

' Clinical instinct' led FDA specialists to support Zevra's uncommon illness med

.Zevra Therapies' unusual disease medication seems to be to be on the pathway to permission this fal...

Pfizer takes $230M reached after axing failed DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene treatment failure has actually gone a $230 mi...

AC Immune sees 'site' prospective in Alzheimer's medication data

.After more than twenty years of focus on neurodegenerative health conditions, Swiss biotech hvac In...

GSK goes down ph. 2 HPV injection over shortage of best-in-class potential

.GSK has broken up a stage 2 human papillomavirus (HPV) vaccine from its own pipe after choosing the...

OS Therapies refiles $6M IPO to money HER2 drug, preclinical ADCs

.Operating system Therapies will certainly specify on the NYSE American inventory exchange today usi...

ALX's waning CD47 response fee sends sell spiraling down

.ALX Oncology's stage 2 stomach cancer cells action cost has actually weakened. After finding its CD...

Ionis centers eye illness from targets of Roche-partnered prospect after data let down

.Another of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of desires, m...

Biogen's CEO mentioned no dangerous sell 2023. He's ready to be vibrant

.While Biogen's pharma peers are looking for late-stage assets with little danger, CEO Chris Viehbac...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Biography has actually been a biotech seeking a pipeline after it junked its lead assets ove...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually handed back civil liberties to an early Alzheimer's ailment course to Denali Re...